1st Quarter - Report

PARRY, ROMANI, DECONCINI & SYMMS for ROCK & ASSOCIATES

Firm
Client
Income
$18,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Appropriations to fund the FDA implementation of compounding pharmacy regulations.

LobbyistCovered position, as disclosed
ROMANO ROMANI —
THADDEUS E STROM —
STEVE SYMMS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.

LobbyistCovered position, as disclosed
ROMANO ROMANI —
THADDEUS E STROM —
STEVE SYMMS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1406 (114th)

Health Issues HCR

Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet.

LobbyistCovered position, as disclosed
ROMANO ROMANI —
THADDEUS E STROM —
STEVE SYMMS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Law Enforcement/Crime/Criminal Justice LAW

Proposals to amend the Controlled Substances Act to clarify the definition of "dispense" to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. No specific legislation yet.

LobbyistCovered position, as disclosed
ROMANO ROMANI —
THADDEUS E STROM —
STEVE SYMMS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.